NCT00431769
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Graz, Austria
- Oberpullendorf, Austria
- Vienna, Austria
- Antwerp, Belgium
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
1,661 public trials
322 recruiting studies
Multiple Myeloma trial results
Completed
Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma
NCT00743288
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Comprehensive Blood and Cancer Center Bakersfield, California, United States
- James R. Berenson MD, Incorporated West Hollywood, California, United States
- Rocky Mountain Cancer Centers - Denver Midtown Denver, Colorado, United States
- Center for Cancer and Blood Disorders Bethesda, Maryland, United States
NCT00901225
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
NCT00507416
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Birmingham Hematology Oncology Assciates, LLC Birmingham, Alabama, United States
- Desert Oasis Cancer Center Casa Grande, Arizona, United States
- Northern Arizona Hematology & Oncology Associates - AOA Sedona, Arizona, United States
- Arizona Oncology Associates Tucson, Arizona, United States
NCT01026701
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
NCT01105403
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Department of Internal Medicine V Heidelberg, Germany
NCT00482846
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chemically-Induced Disorders, +20 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
Completed
Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma
NCT00847639
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
- University of Minnesota Medical Center Minneapolis, Minnesota, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
NCT02095379
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
NCT00322491
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- UCLA School of Medicine Loa Angeles, California, United States
- Loyola University Medical Center Maywood, Illinois, United States
- University of Iowa Iowa City, Iowa, United States